Accomplished molecular microbiologist and protein engineer takes charge of CSIR-IMTECH after serving in key scientific and regulatory leadership roles at FSSAI
Approval expands treatment options for patients with unresectable or metastatic HER2-positive breast cancer
The company gets access to Lonza’s clinically validated SYNtecan linker-payload platform as it prepares an IND filing for its acute myeloid leukemia therapy in 2027
The landmark legislation has laid the foundation for a skilled, regulated and globally competitive Allied and Healthcare Professional workforce, reshaping healthcare education and delivery across India
Bengaluru-based startup will use the fresh capital to enter new markets, enhance technology capabilities, and scale its integrated care model
The move makes EBGLYSS the only therapy offering as few as six maintenance injections per year
Preclinical CRO strengthens leadership team with key executive appointments as it scales its human tissue-based drug discovery platform
Strategic shift from Italy to India strengthens supply chain resilience, expands capacity and enhances sustainability for the growing global UDCA market
The company said Wegovy hit its first one million prescriptions within 12 weeks of availability
The company said data from multiple VESPER studies show the peptide delivered meaningful weight loss, favorable tolerability, and the possibility of a first-in-class monthly injection format
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
